東方通(300379.SZ):擬引入中移資本作為戰略投資者
格隆匯 1 月 27日丨東方通(300379.SZ)公佈,公司於2021年1月27日召開第四屆董事會第十三次會議,審議通過了《關於公司向特定對象發行股票引入戰略投資者並簽署附條件生效的戰略合作協議的議案》,公司擬通過此次向特定對象發行股票引入中移資本控股有限責任公司(“中移資本”)作為戰略投資者。公司擬根據本次向特定對象發行股票的方案,與上述戰略投資者簽署附生效條件的《戰略合作協議》。
中移資本是中國移動通信集團有限公司(“中國移動”)下屬的產業投資機構,是中國移動的全資子公司,負責圍繞中國移動發展戰略、依託中國移動豐厚產業資源開展股權戰略投資,助力中國移動業務發展,持續增強中國移動在產業鏈上下游的影響力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.